MITSUBISHI TANABE PHARMA DEVELOPMENT
New York, NY. (December 14, 2009) – Mitsubishi Tanabe Pharma Development America, Inc. (MTDA), a research driven specialty pharma company, has appointed David Gan, M.D., Dr. P.H., M.P.H. to Executive Director & Head of Drug Safety. EF|IMD International, the executive search division of Epsen Fuller Group, conducted the search leading to the hire of Dr. Gan.
Dr. Gan was most recently the Head of Global Signal Detection and Safety Data Management with Bristol-Myers Squibb. Receiving his Doctor of Medicine degree from TongJi Medical University, Wuhan, China, Dr. Gan earned his M.P.H. and Dr. P.H. in Epidemiology from Tulane University. Board certified by the American Board of Preventive Medicine, he is credentialed as an attending physician at Walter Reed Army Medical Center and was formerly with the FDA with responsibilities including but not limited to Medical Officer and Clinical Safety Reviewer.
“The leadership, deep understanding and track record of success in the field that Dr. Gan brings will provide MTDA the expertise to orchestrate existing initiatives and the strategic guidance required on future drug development programs”, said John Gilbert, Client Partner of Epsen Fuller Group conducted the search from the firm’s New Jersey office.
Dr Gan became a Commissioned Officer Lieutenant Colonel in the United States Army Medical Corps and was deployed to Afghanistan as Medical Director for the Coalition Joint Civil Military Operations Task Force where he supported the United States Department of Defense and the Department of Health and Human Services to develop health related initiatives in this region. As a result of his meritorious service, he was awarded the Bronze Star. He remains in the U.S. Army Reserve as a Preventive Officer, U.S. Walter Reed Army Research Institute.
About Mitsubishi Tanabe Pharma Development America, Inc. (MTDA)
Mitsubishi Tanabe Pharma Development America, Inc. (MTDA), www.mitsubishi-pharma.com, is headquartered in Warren, New Jersey with a drug development pipeline in several therapeutic areas, including nephrology, cardiovascular and central nervous system. The Company’s objective is to emerge as a leader in the U.S. pharmaceutical market, introducing new therapeutics that improve patient treatment options and quality of life.
About Epsen Fuller/IMD International Search Group
New York based Epsen Fuller Group, www.epsenfuller.com, is a Top-20 retained executive search and talent management consulting firm with US offices in New York, New Jersey and San Francisco and offices in major markets and business centers throughout the world, providing instant access to a world-class executive talent pool serving the global economy. Epsen Fuller Group operates under one umbrella and one common platform to deliver an integrated suite of talent management solutions throughout four business units focused on the acquisition, assessment, and acceleration of talent. EF|IMD conducts senior executive search, TalentKinect executes mid- management recruitment projects, iDestiny offers a variety of leadership assessment, development, and coaching solutions, while EFG|Advisory delivers talent assessment and advisory services to enhance governance best practices in corporate Boards and maximize transaction value for Private Equity Groups.
The firm specializes primarily in three primary industry verticals – tech communications & media, pharmaceuticals & life sciences, and the consumer sectors for blue-chip client organizations worldwide.